Published in J Clin Invest on January 26, 2015
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology (2015) 1.56
DNA damage response and sphingolipid signaling in liver diseases. Surg Today (2015) 0.90
Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors. Biomed Res Int (2015) 0.84
Beyond Diabetes: Does Obesity-Induced Oxidative Stress Drive the Aging Process? Antioxidants (Basel) (2016) 0.79
Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective. Evid Based Complement Alternat Med (2016) 0.79
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background. World J Cardiol (2016) 0.79
Pathological polyploidy in liver disease. Hepatology (2015) 0.77
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. Antioxid Redox Signal (2016) 0.77
FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget (2016) 0.77
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World J Gastroenterol (2016) 0.77
Wound-Induced Polyploidization: Regulation by Hippo and JNK Signaling and Conservation in Mammals. PLoS One (2016) 0.77
Liver polyploidy: Dr Jekyll or Mr Hide? Oncotarget (2015) 0.77
Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation. J Clin Transl Hepatol (2016) 0.76
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC. Oncotarget (2017) 0.75
NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis. Cancer Sci (2016) 0.75
A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues. Methods (2016) 0.75
Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep (2017) 0.75
Hepatocyte polyploidization and its association with pathophysiological processes. Cell Death Dis (2017) 0.75
TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure. PLoS One (2016) 0.75
Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. Int J Mol Sci (2016) 0.75
Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression. PLoS One (2016) 0.75
hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury. Mol Ther (2017) 0.75
Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats. Sci Rep (2017) 0.75
Oxidative Stress in Oral Diseases: Understanding Its Relation with Other Systemic Diseases. Front Physiol (2017) 0.75
Acute toxicity and genotoxicity of silver nanoparticle in rats. PLoS One (2017) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (1996) 12.47
Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology (2006) 9.34
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology (2001) 8.09
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010) 5.44
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J (1991) 4.04
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest (2004) 3.92
Organogenesis and development of the liver. Dev Cell (2010) 3.71
The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature (2010) 3.27
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol (2012) 2.89
Reactive oxygen species in tumor progression. Front Biosci (2005) 2.72
The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol (2011) 2.54
Cyclin A in cell cycle control and cancer. Cell Mol Life Sci (2002) 2.49
Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell (2010) 2.45
ATR signalling: more than meeting at the fork. Biochem J (2011) 2.37
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med (2011) 2.34
Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 2.32
Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology (2004) 2.22
NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol (2013) 2.20
Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem (2003) 2.18
Hepatic polyploidy and liver growth control. Semin Cancer Biol (2000) 2.14
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology (2001) 2.14
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology (2007) 2.09
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology (2009) 2.00
Hepatic steatosis: innocent bystander or guilty party? Hepatology (1998) 1.94
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol (2002) 1.86
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med (2009) 1.80
Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol (2012) 1.79
Endoreplication and polyploidy: insights into development and disease. Development (2013) 1.66
How dormant origins promote complete genome replication. Trends Biochem Sci (2011) 1.60
Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol (1999) 1.60
Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci U S A (2012) 1.55
Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome. Gut (2012) 1.50
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology (2013) 1.42
Liver tetraploidization is controlled by a new process of incomplete cytokinesis. J Cell Sci (2007) 1.42
Quality control in the initiation of eukaryotic DNA replication. Philos Trans R Soc Lond B Biol Sci (2011) 1.40
E2F8 is essential for polyploidization in mammalian cells. Nat Cell Biol (2012) 1.39
Canonical and atypical E2Fs regulate the mammalian endocycle. Nat Cell Biol (2012) 1.37
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology (2008) 1.37
The insulin/Akt pathway controls a specific cell division program that leads to generation of binucleated tetraploid liver cells in rodents. J Clin Invest (2009) 1.36
AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J (2007) 1.30
Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res (2007) 1.30
Frequent aneuploidy among normal human hepatocytes. Gastroenterology (2011) 1.30
Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology (2004) 1.30
Aneuploidy, polyploidy and ploidy reversal in the liver. Semin Cell Dev Biol (2013) 1.26
Phosphorylation network dynamics in the control of cell cycle transitions. J Cell Sci (2012) 1.26
p53: guardian of ploidy. Mol Oncol (2011) 1.25
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol (2011) 1.25
[Somatic polyploid cells in rat liver. I. The role of binuclear cells in the formation of the polyploid cells]. Exp Cell Res (1966) 1.24
Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis (2009) 1.24
Aneuploidy as a mechanism for stress-induced liver adaptation. J Clin Invest (2012) 1.23
Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem (2010) 1.22
Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 1.22
Polyploidy associated with oxidative injury attenuates proliferative potential of cells. J Cell Sci (2001) 1.20
Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth. Nat Rev Mol Cell Biol (2014) 1.19
PPARγ contributes to PKM2 and HK2 expression in fatty liver. Nat Commun (2012) 1.18
Polyploidization of liver cells. Adv Exp Med Biol (2010) 1.17
Physiological significance of polyploidization in mammalian cells. Trends Cell Biol (2013) 1.16
Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif (1993) 1.14
The ATM signaling network in development and disease. Front Genet (2013) 1.09
Polyploidy and liver proliferation. Clin Res Hepatol Gastroenterol (2011) 1.09
Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS One (2011) 1.08
Immunofluorescent detection of two thymidine analogues (CldU and IdU) in primary tissue. J Vis Exp (2010) 1.07
Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling. Cell Metab (2008) 1.02
Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Lab Invest (2006) 1.02
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res (2008) 1.02
Polyploidization in liver tissue. Am J Pathol (2013) 1.01
Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism (1994) 1.00
Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis. Gut (2005) 0.99
NAFLD, obesity, and bariatric surgery. Gastroenterology (2006) 0.98
Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. Nutr J (2003) 0.98
Polyploidy and liver proliferation: central role of insulin signaling. Cell Cycle (2010) 0.97
Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int J Exp Pathol (2011) 0.96
Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care (2012) 0.96
Genomic aspects of NAFLD pathogenesis. Genomics (2013) 0.95
Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes. J Hepatol (2005) 0.82
Increased polyploidy, delayed mitosis and reduced protein phosphatase-1 activity associated with excess copper in the Long Evans Cinnamon rat. Res Commun Mol Pathol Pharmacol (1998) 0.79
cAMP-dependent positive control of cyclin A2 expression during G1/S transition in primary hepatocytes. Biochem Biophys Res Commun (1999) 0.79
Fe(II)/Cu(I)-dependent P-type ATPase activity in the liver of Long-Evans cinnamon rats. Life Sci (2005) 0.77
Hepatic ploidy, nuclearity, and distribution of DNA synthesis: a comparison of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Toxicol Appl Pharmacol (1997) 0.77
Conserved balance of hepatocyte nuclear DNA content in mononuclear and binuclear hepatocyte populations during the course of chronic viral hepatitis. World J Gastroenterol (2006) 0.76
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology (2007) 3.61
Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol (2006) 3.14
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion (2006) 2.68
Changing trends in malignant transformation of hepatocellular adenoma. Gut (2011) 2.28
Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem (2003) 2.18
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology (2004) 2.08
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med (2011) 2.03
Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection. Liver Int (2011) 1.84
Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. J Cell Biol (2006) 1.80
Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology (2003) 1.79
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int (2009) 1.76
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology (2009) 1.70
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology (2012) 1.64
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int (2011) 1.64
The intraflagellar transport component IFT88/polaris is a centrosomal protein regulating G1-S transition in non-ciliated cells. J Cell Sci (2007) 1.61
Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol (2009) 1.58
Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg (2009) 1.56
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology (2005) 1.52
Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol (2009) 1.49
Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology (2005) 1.48
MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol (2012) 1.47
Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology (2012) 1.46
NASH: a mitochondrial disease. J Hepatol (2005) 1.45
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology (2013) 1.42
Liver tetraploidization is controlled by a new process of incomplete cytokinesis. J Cell Sci (2007) 1.42
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. J Pathol (2010) 1.41
Liver extracellular matrix in health and disease. J Pathol (2003) 1.40
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol (2009) 1.39
The insulin/Akt pathway controls a specific cell division program that leads to generation of binucleated tetraploid liver cells in rodents. J Clin Invest (2009) 1.36
Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity (2011) 1.35
Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology (2002) 1.35
Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol (2008) 1.34
Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol (2010) 1.32
Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.27
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol (2006) 1.26
Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol (2004) 1.26
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology (2012) 1.24
Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol Clin Exp Res (2002) 1.23
Polyploidization of liver cells. Adv Exp Med Biol (2010) 1.17
Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology (2010) 1.14
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol (2006) 1.14
Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology (2011) 1.14
Cdc42-mediated MTOC polarization in dendritic cells controls targeted delivery of cytokines at the immune synapse. J Exp Med (2010) 1.13
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology (2007) 1.11
Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver. Am J Pathol (2003) 1.11
Central role of mitochondria in drug-induced liver injury. Drug Metab Rev (2011) 1.10
Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. Semin Liver Dis (2007) 1.08
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther (2004) 1.07
Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J Biol Chem (2009) 1.05
Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol (2009) 1.04
Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease. EMBO Mol Med (2013) 1.04
Temporal control of contractile ring assembly by Plo1 regulation of myosin II recruitment by Mid1/anillin. Curr Biol (2011) 1.04
Molecular cloning of CoA Synthase. The missing link in CoA biosynthesis. J Biol Chem (2002) 1.02
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol (2008) 1.02
Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology (2013) 1.02
Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology (2012) 1.01
Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FEBS Lett (2005) 1.00
Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther (2007) 1.00
Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology (2011) 0.99
Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice. Hepatology (2005) 0.98
Polyploidy and liver proliferation: central role of insulin signaling. Cell Cycle (2010) 0.97
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer (2012) 0.97
Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol (2010) 0.97
Interplay between FGF10 and Notch signalling is required for the self-renewal of pancreatic progenitors. Int J Dev Biol (2006) 0.97
High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology (2013) 0.97
S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy. J Clin Invest (2011) 0.96
Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int J Exp Pathol (2011) 0.96
Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver. Lab Invest (2011) 0.95
Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int (2005) 0.95
Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology (2006) 0.95
p63 gene expression study and early bladder carcinogenesis. Urology (2007) 0.95
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. Hepatology (2014) 0.94
Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J Pharmacol Exp Ther (2009) 0.93
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma. J Hepatol (2010) 0.93
Selective portal vein ligation and embolization induce different tumoral responses in the rat liver. Surgery (2010) 0.93
Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression. Biochem Soc Trans (2013) 0.92
Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl (2004) 0.92
Subcellular localization and regulation of coenzyme A synthase. J Biol Chem (2003) 0.92
Extended liver resection for polycystic liver disease can challenge liver transplantation. Ann Surg (2010) 0.91
Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol (2012) 0.91
Hepatocytes polyploidization and cell cycle control in liver physiopathology. Int J Hepatol (2012) 0.91
Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J Biol Chem (2002) 0.91
Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl (2007) 0.91
Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity. FEBS J (2011) 0.91
Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency. Obesity (Silver Spring) (2008) 0.90
Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab (2008) 0.90
Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology (2003) 0.90
Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments. Antimicrob Agents Chemother (2003) 0.90
Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am J Pathol (2009) 0.90
KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis. Am J Pathol (2011) 0.90